Evidence of proatherogenic inflammation in polycystic ovary syndrome. - Wikidata - awgldk - TriplyDB

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

http://www.wikidata.org/entity/Q37332527

about

Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation.Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.Identification and treatment of metabolic complications in pediatric obesity.The physiological basis of complementary and alternative medicines for polycystic ovary syndrome.Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).Evidence of mononuclear cell preactivation in the fasting state in polycystic ovary syndrome A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes.Serum Heat Shock Protein 70 Concentration in Relation to Polycystic Ovary Syndrome in a Non-Obese Chinese Population.Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis.No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls.Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome.Polycystic ovary syndrome: current status and future perspective Mindfulness-based stress reduction for overweight/obese women with and without polycystic ovary syndrome: design and methods of a pilot randomized controlled trial.Serum tumor necrosis factor-α, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility Genetic variation in the Mcp-1 gene promoter associated with the risk of polycystic ovary syndrome.Is PCOS an inflammatory process?The effects of old, new and emerging medicines on metabolic aberrations in PCOS.Hyperandrogenism exerts an anti-inflammatory effect in obese women with polycystic ovary syndrome.Glucose ingestion stimulates atherothrombotic inflammation in polycystic ovary syndrome.Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome Hepatic steatosis in overweight/obese females: new screening method for those at risk Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease.Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs.Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.Soluble platelet/endothelial cell adhesion molecule (sPECAM)-1 is increased in polycystic ovary syndrome and related to endothelial dysfunction.Serum high-sensitivity C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, matched study.Elevated circulating levels of tissue factor in polycystic ovary syndrome.Association study of HNF1A in women with polycystic ovary syndrome.Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.Levels of CD40L and other inflammatory biomarkers in obese and non-obese women with polycystic ovary syndrome.Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).Effect of colchicine on polycystic ovary syndrome: an experimental study.High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.

P2860

Q26771828-3896428B-348D-4E2C-BB71-6A753EFE21C5 Q27011541-B55BC250-13E9-4D04-9901-2EB6CE0675D4 Q30384617-E8FA302C-CADA-4C07-81B8-A50F0573CD41 Q33559740-86D23DE2-8BE8-4663-8718-E0161A4DE4B5 Q33750620-6D579D1B-3AC6-4E9D-999A-1527AA8EF3DF Q33893011-2ABDAE54-5A0A-4716-AE61-058704CD2CEF Q34026512-2771A880-B87D-4DD1-B74F-D32C2EB7A42D Q34396231-38D02C21-C536-4D4E-ADB7-3F009CBD25E0 Q34620242-42C29248-E931-494A-96FC-BA9F4163251A Q34684209-3080A207-14ED-464B-BB01-7B21CF3D171A Q34795100-94521377-AB34-45F8-9F5C-E85D01C8F973 Q34817037-5F95EF00-F199-4F57-A9BE-8771B9B989BC Q34987386-3CC65F72-7A7F-4EB4-B5EC-A183574B7A43 Q35114712-EFFA21D4-9D0B-44C1-A731-9D6F2605030A Q35124537-B9D55D8A-C033-4B4F-B58F-F891015F44AB Q35235594-429C0813-606F-4A07-90C7-6F6EFD8403D7 Q35320690-D6A23300-986A-4F2F-B076-5980A4FD8A91 Q35527825-81D6D879-5D45-4188-B282-076A29581036 Q35633277-0B7FC1D6-AD16-4B4D-840D-BF5FFE547223 Q36328060-4D72D52E-2188-499D-A73F-38CE60A9A524 Q36369187-D7A7CC7A-59F3-4443-ADAF-745136671F28 Q36593085-D51BCCF6-197D-4551-8F18-3C10C573379F Q37057444-79C4C44A-244B-401F-9817-143E099EEA3F Q37410552-E73ACDD1-0A84-40E7-B7F2-FAD7758488D6 Q37422832-CAEC2C53-1026-43EE-910B-9986DFACCCD0 Q37461182-F276692B-0395-4F96-B6BB-5A86A9DA2556 Q37830746-722634CD-0439-4B04-B8CC-B0557E3681B5 Q38247074-F3E18D1B-8AE8-4839-9A8C-77FC60B679EE Q38710863-1B047E09-71C7-41D4-86B8-E8CB630C9815 Q39202594-FC994CF2-0422-46CB-A37C-C07762554A62 Q40867121-79FBE087-3F66-4472-921A-90336485FF85 Q42504156-383077EC-AC87-4AEB-AE4F-23FE95CBFE14 Q43098000-63962C96-3D17-4A06-BA7B-10728AB27245 Q46658751-B4AD75BD-455D-4C25-9B97-D363E81B0410 Q47417124-B4E12FA0-D5B6-4CA3-9DE9-0A49488709F4 Q51391379-4F220A84-3720-4CBD-BBFD-EB54F26C4BDD Q51544386-418441BB-0FB3-4562-BA02-E59D890E1B15 Q52841821-B48E346F-4CCC-4616-AFAA-A67F0AAC472C Q53291647-EC62CECF-E35C-460F-837F-AD97DA57E8F2 Q53753200-AAEF6021-F891-412D-B740-EB975F1E6B91

P2860

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

http://www.wikidata.org/entity/Q37332527

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@en

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@nl

type

label

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@en

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@nl

prefLabel

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@en

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@nl

P1433

Q37332527-3FA92B20-537A-49BF-86F4-ECA20CF2879B

P1476

Q37332527-1B87F1F8-24F8-4E0E-9E57-6706AC3A6BF8

P2093

Q37332527-3D43F244-5BC9-4F8B-84C8-6ABE37EF4DFE

Q37332527-B02F2729-DAF8-4496-84F7-5592C31A6164

Q37332527-F74627F6-8D52-4C50-AF4E-21E4C74877DF

Q37332527-FCB23B2F-2919-498F-8B40-465B13888440

P2860

Q37332527-02CF6C23-7417-42A0-B468-60CD1C5E4F70

Q37332527-063DC5E2-0818-43EC-974F-1C2573BE6FDB

Q37332527-0E753EC7-E134-4F68-8B69-35B0AD635AF1

Q37332527-0F85895D-00E6-40E3-AFD6-59387F2CFAA1

Q37332527-11C26ADC-1E0C-4876-953E-885F239CFCFB

Q37332527-18621AE1-536E-4718-A17B-2E10ADCF0D51

Q37332527-1F72D0D2-F291-460A-988E-582D25EDC5D8

Q37332527-2DB75DB6-0640-4CC7-AD5B-E32FFA936A2B

Q37332527-2FEFB8FC-0688-45E7-B1A3-14B37D66D0E8

Q37332527-30AA00E7-1E58-4A7E-A9F6-37A5C3090395

P304

Q37332527-754ABE33-F4F6-423B-A3D1-DE0837A78DEF

P31

Q37332527-E5BF4E1F-7E43-469C-B6A6-4031E8A6CEDE

P356

Q37332527-47434413-A4F4-4DEC-B478-48B36F7992D5

P433

Q37332527-28704AE1-1AD9-4381-93C4-EFBA6CD0C730

P478

Q37332527-5CAFFF92-6E13-4819-94CD-6E9FA428DD5C

P577

Q37332527-2E3769BA-2A5F-452A-AE42-DF98935B1F0A

P5875

Q37332527-5C986FE8-A8EF-491E-BB82-3A3B3B5B5CB0

P698

Q37332527-667F440D-03CA-43F8-8516-563B5CB410AA

P921

Q37332527-1067A9DB-E00B-4A3F-B6C8-EB349C451C0C

Q37332527-44000CB4-6A70-4BD5-8A83-97A9F5D81A5D

P932

Q37332527-77A89CF9-E7E5-41EA-B956-BCF4C5EF5D9C

P356

J.METABOL.2009.02.022

P1433

P1476

Evidence of proatherogenic inflammation in polycystic ovary syndrome.

@en

P2093

Frank González

http://www.w3.org/2001/XMLSchema#string

John P Kirwan

http://www.w3.org/2001/XMLSchema#string

Judi Minium

http://www.w3.org/2001/XMLSchema#string

Neal S Rote

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Obesity is associated with macrophage accumulation in adipose tissue

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Inflammation in atherosclerosis

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1.

P304

954-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.METABOL.2009.02.022

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24306852

http://www.w3.org/2001/XMLSchema#string

P698

19375763

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

2737595

http://www.w3.org/2001/XMLSchema#string